CytomX Therapeutics, Inc. ( CTMX) - Key Metrics
CTMX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0 | -$0.16 | -$0.14 | -$0.14 |
| 2025Q3 | $0.04 | -$0.09 | -$0.09 | -$0.09 |
| 2025Q2 | $0.14 | $0 | -$0.12 | -$0.12 |
| 2025Q1 | $0.58 | $0.27 | -$0.24 | -$0.24 |
CTMX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | -11.32% | -6.84 |
| 2025Q3 | ? | -9.25 |
| 2025Q2 | ? | -475.65 |
| 2025Q1 | ? | 0.59 |
CTMX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -3.07% | ? |
| 2025Q4 | -3.23% | 0.41% |
| 2025Q3 | -2.93% | ? |
| 2025Q2 | -5.39% | ? |
| 2025Q1 | -38.20% | ? |
CTMX
Price: $2.92
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.52 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 865300
Ebitda: -10.5 millionMarket Capitalization: 482.5 million